Henry Levy is chief strategy officer at Veeva, where he leads Veeva's market strategy and key customer and partner collaborations to advance the life sciences industry, including clinical operations and data management. Henry has spent 25 years working to transform how the $1.7 trillion life sciences industry improves patient health. He also represents Veeva as president of Align Biopharma and Align Clinical CRO, two industry standards groups dedicated to improving how healthcare providers engage life sciences companies, as well as making it easier for sponsors and CROs to work together during clinical trials, respectively.
Prior to Veeva, Henry was chief commercial officer for PPD, where he defined new models for biopharma companies to partner with contract research organizations, drive down costs, and improve the speed of drug development. Before that, he led Accenture's global life sciences R&D practice, helping the industry improve through consulting, technology, and outsourcing solutions. In his role, Henry worked with 90% of the top 20 biopharmaceutical companies and provided Accenture leadership to industry groups such as TransCelerate and Hever.
Henry has published multiple articles on clinical development and technology trends, and is a frequent speaker at industry forums. He currently is on the board of Alliance for Clinical Research Excellence and Safety. He holds a bachelor of science degree in bioengineering from the University of Pennsylvania.